Strain Imaging: Definition, Clinical Significance, and Overview

Strain Imaging Introduction (What it is)

Strain Imaging measures how much the heart muscle deforms as it contracts and relaxes.
It is a cardiac imaging assessment used most often during echocardiography and sometimes with cardiac magnetic resonance (CMR).
It describes myocardial function beyond left ventricular ejection fraction (LVEF).
It is commonly used in heart failure, cardiomyopathies, ischemic heart disease, and cardio-oncology follow-up.

Clinical role and significance

Strain Imaging matters because myocardial dysfunction often begins before global pump function (such as LVEF) visibly declines. In cardiology, many decisions depend on detecting early or subtle changes in ventricular performance, differentiating disease patterns, and tracking response over time.

Clinically, Strain Imaging is used as a functional marker of myocardial mechanics—how the myocardium shortens, lengthens, and thickens during the cardiac cycle. This can support:

  • Diagnosis: identifying characteristic deformation patterns seen in specific cardiomyopathies (for example, infiltrative disease) or regional ischemia.
  • Risk stratification: adding context in patients with preserved or borderline LVEF, where symptoms or biomarkers suggest higher risk.
  • Monitoring: following myocardial function during potentially cardiotoxic therapies, after myocardial infarction, or during chronic heart failure management.
  • Pre- and peri-procedural assessment: complementing standard transthoracic echocardiography (TTE) when decisions depend on ventricular function, loading conditions, and regional wall mechanics.

Strain is not a replacement for history, physical examination, electrocardiography (ECG), biomarkers (such as troponin or natriuretic peptides), or standard imaging measures. Instead, it is typically interpreted alongside LVEF, chamber size, wall thickness, diastolic parameters, and valvular assessment to form a coherent physiologic picture.

Indications / use cases

Typical scenarios where Strain Imaging is considered include:

  • Suspected or established heart failure, including heart failure with preserved ejection fraction (HFpEF) evaluation support
  • Cardio-oncology surveillance for subclinical myocardial dysfunction during or after potentially cardiotoxic therapy (practice varies by clinician and case)
  • Cardiomyopathies, such as hypertrophic cardiomyopathy (HCM), dilated cardiomyopathy (DCM), and infiltrative conditions (e.g., amyloidosis patterns may be discussed)
  • Suspected myocarditis or inflammatory myocardial injury, as an adjunct to other clinical and imaging findings
  • Ischemic heart disease, including assessment of regional function in suspected coronary artery disease or after acute coronary syndrome (ACS)
  • Valvular heart disease, to support assessment of ventricular performance and timing discussions (interpreted with valve severity, symptoms, and hemodynamics)
  • Right ventricular (RV) function assessment, including pulmonary hypertension and congenital heart disease follow-up (context-dependent)
  • Atrial function, such as left atrial (LA) strain as a functional adjunct in diastolic dysfunction and atrial fibrillation evaluation (use varies by lab and device)

Contraindications / limitations

Strain Imaging is an analysis method rather than a therapy, so it has few absolute “contraindications.” The practical limitations usually relate to image quality, patient factors, and interpretive constraints.

Situations where Strain Imaging may be less suitable or where alternative approaches may be preferred include:

  • Poor acoustic windows on echocardiography (obesity, lung disease, chest wall factors), limiting tracking reliability
  • Arrhythmias (especially atrial fibrillation with beat-to-beat variability) that complicate consistent measurements
  • High heart rate or frequent ectopy, which can reduce tracking stability and reproducibility
  • Significant valvular regurgitation or stenosis with unusual loading conditions, where strain interpretation requires caution
  • Bundle branch block or pacing (dyssynchrony), where deformation patterns may reflect electrical timing as much as contractility
  • Inadequate frame rate or suboptimal acquisition settings for echocardiographic strain
  • Vendor/software variability, which can make absolute strain values less comparable across platforms
  • When CMR is needed for tissue characterization (scar/fibrosis, edema), Strain Imaging by echo may be complementary but not sufficient; CMR-based methods may be more informative depending on the question

If echocardiographic strain is not feasible, clinicians may rely more on standard echocardiography, contrast-enhanced echo (where available), CMR, computed tomography (CT) in selected structural contexts, or serial clinical assessment and biomarkers—depending on the clinical scenario.

How it works (Mechanism / physiology)

Strain describes deformation, expressed as the percent change in length of myocardial fibers relative to their original length. In simple terms:

  • Negative strain typically reflects shortening (common for left ventricular longitudinal and circumferential strain during systole).
  • Positive strain can reflect thickening (often radial strain) or lengthening during relaxation phases, depending on the convention and axis.

Key physiologic and anatomic concepts:

  • The myocardium has layered fiber architecture. Subendocardial fibers contribute prominently to longitudinal shortening, which can be sensitive to early injury (e.g., ischemia or diffuse fibrosis).
  • The left ventricle (LV) contracts in multiple directions:
  • Longitudinal strain (base-to-apex shortening)
  • Circumferential strain (around the LV short-axis)
  • Radial strain (wall thickening)
  • Strain can also be assessed in the right ventricle (often longitudinal) and the atria (reservoir, conduit, and booster phases for LA strain, depending on method and rhythm).

How Strain Imaging is derived depends on modality:

  • Speckle-tracking echocardiography (STE): tracks natural acoustic “speckles” within the myocardium frame-to-frame on 2D (and sometimes 3D) echo images to calculate deformation.
  • Tissue Doppler imaging (TDI) strain: uses Doppler-derived velocities to estimate deformation along the ultrasound beam; it is angle-dependent.
  • CMR feature tracking: follows myocardial features on cine CMR images to estimate strain; acquisition differs from echo and can be useful when echo windows are limited.

“Onset and duration” are not applicable in the way they are for medications or procedures. Instead, strain is a measurement at a point in time, and its clinical value often comes from serial comparison (trend over time) and correlation with symptoms, hemodynamics, and other tests.

Strain Imaging Procedure or application overview

Strain Imaging is typically an add-on analysis performed during or after standard cardiac imaging. A general workflow is:

  1. Evaluation/exam – Clinical question is defined (e.g., unexplained dyspnea, chemotherapy monitoring, cardiomyopathy assessment). – Baseline tests (history, exam, ECG, labs) inform the pre-test probability.

  2. Diagnostics – A standard transthoracic echocardiogram (TTE) is performed first in many cases, assessing chamber sizes, LVEF, wall motion, valvular function, and diastolic indices. – If needed, transesophageal echocardiography (TEE), stress echocardiography, or CMR may be used depending on the question.

  3. Preparation – For echocardiography, preparation is minimal (positioning, ECG leads, optimization of imaging windows). – For CMR, screening for device compatibility and standard institutional protocols are followed (details vary by institution).

  4. Intervention/testing (measurement and analysis) – Images are acquired with attention to adequate frame rate and clear endocardial definition (echo). – The LV is typically segmented, and software tracks the myocardium across the cardiac cycle. – A common summary metric is global longitudinal strain (GLS), along with segmental strain values when relevant.

  5. Immediate checks – The operator reviews tracking quality and may repeat views if tracking is poor. – Results are interpreted alongside LVEF, wall motion, Doppler findings, and clinical context.

  6. Follow-up/monitoring – When used for surveillance, repeat studies aim for consistent acquisition and analysis methods to improve comparability. – Changes are interpreted cautiously because values can vary by device, software version, loading conditions, and rhythm.

Types / variations

Strain Imaging can be described by modality, chamber, and strain direction.

Common variations include:

  • By imaging modality
  • 2D speckle-tracking echocardiography (2D STE): widely used; provides GLS and segmental strain.
  • 3D speckle-tracking echocardiography (3D STE): can assess deformation in 3D; feasibility depends on image quality and equipment.
  • TDI-derived strain/strain rate: older approach in many labs; angle dependence is a key limitation.
  • CMR feature tracking: uses cine images; may be helpful when echo windows are limited or when CMR is already being performed.
  • Tagged CMR: specialized technique for deformation; availability varies by institution.

  • By chamber

  • LV strain: most common, especially GLS.
  • RV free-wall strain: used in pulmonary hypertension, RV cardiomyopathies, congenital heart disease follow-up (context dependent).
  • LA strain: used as an adjunct in diastolic function assessment and atrial fibrillation-related evaluation; interpretation varies with rhythm and loading.

  • By direction/metric

  • Longitudinal, circumferential, radial strain
  • Strain rate: rate of deformation over time; can be more sensitive to temporal changes but may be noisier and more dependent on acquisition quality.

Advantages and limitations

Advantages:

  • Can detect subtle myocardial dysfunction that may not change LVEF initially.
  • Provides quantitative assessment that may improve trend monitoring when performed consistently.
  • Offers regional and global functional information (segmental strain vs GLS).
  • Can complement standard echocardiographic interpretation in ischemia and cardiomyopathies.
  • Useful for serial surveillance in selected populations (practice varies by clinician and case).
  • Adds physiologic context in patients with symptoms despite “normal” conventional measures.

Limitations:

  • Strongly dependent on image quality and acquisition settings (especially in echocardiography).
  • Inter-vendor and inter-software variability can limit comparability of absolute values.
  • Loading conditions (blood pressure, volume status, valvular disease) can influence strain, complicating interpretation.
  • Arrhythmias and pacing can reduce reproducibility or alter deformation patterns.
  • Requires training and quality control to avoid misleading results from poor tracking.
  • Not a stand-alone diagnosis; must be interpreted with clinical context and other imaging findings.

Follow-up, monitoring, and outcomes

How Strain Imaging is used over time depends on the clinical setting, baseline risk, and the question being asked. In general, monitoring and outcomes are influenced by:

  • Baseline disease severity: advanced heart failure, extensive infarction, or significant cardiomyopathy may show more pronounced abnormalities.
  • Comorbidities: hypertension, diabetes, chronic kidney disease, lung disease, and anemia can affect symptoms and cardiac loading conditions.
  • Rhythm and conduction: atrial fibrillation, left bundle branch block, and paced rhythms can affect deformation patterns and measurement consistency.
  • Hemodynamics and loading: blood pressure, fluid status, and valvular lesions can change strain values independent of intrinsic contractility.
  • Consistency of technique: serial comparisons are most interpretable when the same modality, vendor/software, and acquisition protocol are used (varies by device and institution).
  • Therapy and adherence (general): medical therapy for heart failure, revascularization in ischemic disease, or valve interventions may change strain over time, but the direction and magnitude vary by clinician and case.

Follow-up intervals are not universal. They are typically individualized based on the condition (e.g., cardio-oncology surveillance vs chronic cardiomyopathy) and institutional protocols.

Alternatives / comparisons

Strain Imaging is one tool among many for assessing myocardial function. High-level comparisons include:

  • Versus LVEF (standard echocardiography):
  • LVEF is widely available and familiar but may be less sensitive to early dysfunction.
  • Strain adds a quantitative deformation measure that can highlight subtle changes, but it is more dependent on image quality and software.

  • Versus wall motion assessment:

  • Visual wall motion scoring is clinically useful in ischemia and acute care but is subjective.
  • Strain can provide more quantitative regional assessment, though it can be affected by tracking artifacts.

  • Versus biomarkers (troponin, BNP/NT-proBNP):

  • Biomarkers reflect injury or hemodynamic stress and can change rapidly.
  • Strain reflects mechanical performance and may complement biomarkers in monitoring, especially when trends are followed.

  • Versus CMR (including late gadolinium enhancement):

  • CMR provides tissue characterization (scar, fibrosis, edema) that strain alone cannot.
  • Echo-based strain is more accessible and portable, while CMR is more resource-intensive and may be limited by availability or patient factors.

  • Versus CT and nuclear imaging:

  • CT coronary angiography evaluates coronary anatomy; nuclear imaging assesses perfusion and viability in selected contexts.
  • Strain focuses on mechanics and may support functional interpretation but does not directly image coronary stenosis or perfusion.

The “best” modality depends on the clinical question, local expertise, patient factors, and availability.

Strain Imaging Common questions (FAQ)

Q: Is Strain Imaging the same as ejection fraction (EF)?
No. EF estimates the percentage of blood ejected from the left ventricle per beat, while strain measures myocardial deformation (how the muscle shortens or thickens). They often correlate but can diverge, especially early in disease.

Q: Does Strain Imaging hurt or involve needles?
When performed with transthoracic echocardiography, it is noninvasive and typically painless. The analysis is done on ultrasound images and does not require injections in standard echocardiography. Other imaging pathways (like CMR with contrast) depend on the broader test being performed.

Q: Do I need anesthesia or sedation for Strain Imaging?
Not for standard transthoracic echocardiography with strain analysis. Sedation may be used if strain is derived from transesophageal echocardiography, but that relates to the TEE procedure rather than strain itself. Requirements vary by institution and patient factors.

Q: How long does Strain Imaging take?
It usually adds a small amount of time to a standard echocardiogram for acquisition and post-processing. The exact duration depends on image quality, the software workflow, and whether additional chambers (RV or LA) are analyzed. Timing varies by lab and case.

Q: How safe is Strain Imaging?
Ultrasound-based strain analysis uses standard diagnostic echocardiography, which is generally considered safe in routine clinical practice. The main “risk” is interpretive—poor image quality or inconsistent methods can lead to unreliable values. CMR-based strain has the safety considerations of CMR in general, which vary by patient and institution.

Q: What does an “abnormal strain” result mean?
It indicates altered myocardial deformation compared with expected patterns, but it does not specify a single diagnosis. Abnormal strain can be influenced by ischemia, cardiomyopathy, inflammation, loading conditions, conduction abnormalities, and technical factors. Interpretation should be integrated with symptoms, ECG, labs, and other imaging findings.

Q: Can Strain Imaging diagnose coronary artery disease?
Strain findings may suggest regional dysfunction consistent with ischemia, but strain alone does not directly image coronary arteries. Clinicians typically use it alongside clinical assessment and other tests such as stress testing, CT coronary angiography, invasive coronary angiography, or perfusion imaging, depending on the scenario.

Q: How often is Strain Imaging repeated for monitoring?
There is no single schedule that fits all patients. Repeat testing depends on the clinical context (for example, surveillance during certain therapies, follow-up after myocardial infarction, or chronic cardiomyopathy monitoring). Monitoring intervals vary by clinician and case.

Q: How much does Strain Imaging cost?
Cost depends on whether it is billed as part of an echocardiogram or as additional analysis, and it varies by region, insurer, and institution. Out-of-pocket costs, coverage rules, and coding practices differ widely. A local imaging center or billing office can clarify typical charges.

Q: Do strain results “last,” or can they change quickly?
Strain is a measurement at a specific time and can change with clinical status. It may shift with blood pressure, volume status, acute ischemia, recovery after an event, or progression of cardiomyopathy. For this reason, trends are usually interpreted in the context of overall hemodynamics and clinical course.

Leave a Reply